Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis

In April 2017 midostaurin was approved by the US Food and Drug Administration for the treatment of patients with aggressive systemic mastocytosis (ASM). So far, very limited real world data on its efficacy is available. Thirteen patients aged from 48 to 79 years, who received midostaurin in the earl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Med
Main Authors: Szudy-Szczyrek, Aneta, Bachanek-Mitura, Oliwia, Gromek, Tomasz, Chromik, Karolina, Mital, Andrzej, Szczyrek, Michał, Krupski, Witold, Szumiło, Justyna, Kanduła, Zuzanna, Helbig, Grzegorz, Hus, Marek
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961806/
https://ncbi.nlm.nih.gov/pubmed/33799933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051109
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker